FIELD: medicine.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry and concerns a banking, perfusion and/or reperfusion solution for an organ, especially heart to be grafted. The solution contains proteinkinase C peptide inhibitor.
EFFECT: method of applying said solution is also described, including banking process for ischemic organ protection against the damage for relieving post-ischemic organ dysfunction for maintaining nitrogen oxide release and/or superoxide release inhibition in an ischemic organ, as well as for organ protection from the damages when isolated from the blood circulatory system.
24 cl, 1 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SOLUTION FOR PERFUSION AND/OR PRESERVATION OF ORGANS AND WAYS OF ITS APPLICATION | 2006 |
|
RU2397641C2 |
| USE OF RASBURICASE FOR TREATING OR PREVENTING CARDIAC DISORDERS OR INDIRECT COMPLICATIONS CAUSED BY ISCHEMIC STROKES OR REPERFUSION | 2008 |
|
RU2482187C2 |
| METHOD FOR PRESERVING MYOCARDIUM ACCOMPANYING TRANSPLANTATION | 2013 |
|
RU2535036C1 |
| METHOD FOR REDUCTION OF OXIDISING INJURY (VERSIONS) | 2005 |
|
RU2376028C2 |
| APPLICATION OF CARIPORIDE FOR DECREASING UNFAVORABLE IMPACT OF MACROLIDE ANTIBIOTICS IN CASE OF CARDIAC ISCHEMIA AND REPERFUSION | 1998 |
|
RU2252754C2 |
| METHOD FOR RECONDITIONING A DONOR HEART | 2021 |
|
RU2777097C1 |
| APPLICATION OF KAURAN COMPOUNDS FOR MEDICINES PRODUCTION | 2004 |
|
RU2345761C2 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| METHOD OF PRESERVATION OF A DONOR HEART | 2020 |
|
RU2743235C1 |
| METHOD FOR PROTECTING THE MYOCARDIUM FROM ISCHEMIC AND REPERFUSION INJURY IN AN EXPERIMENT | 2021 |
|
RU2776770C1 |
